Figure 3.
Serial neoplastin prothrombin determinations on the first and third day of dosing in patients receiving rivaroxaban 10 mg daily. From Mills et al.41
Serial neoplastin prothrombin determinations on the first and third day of dosing in patients receiving rivaroxaban 10 mg daily. From Mills et al.41